Renaissance Technologies’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$110K Sell
34,797
-2,713
-7% -$8.57K ﹤0.01% 3286
2025
Q1
$119K Buy
37,510
+1,478
+4% +$4.7K ﹤0.01% 3165
2024
Q4
$176K Sell
36,032
-4,300
-11% -$21K ﹤0.01% 3198
2024
Q3
$181K Buy
40,332
+14,635
+57% +$65.7K ﹤0.01% 3144
2024
Q2
$212K Buy
25,697
+4,600
+22% +$37.9K ﹤0.01% 3027
2024
Q1
$110K Buy
21,097
+2,300
+12% +$12K ﹤0.01% 3352
2023
Q4
$52K Buy
18,797
+3,200
+21% +$8.85K ﹤0.01% 3448
2023
Q3
$46K Buy
15,597
+5,200
+50% +$15.3K ﹤0.01% 3416
2023
Q2
$52K Sell
10,397
-1,271
-11% -$6.36K ﹤0.01% 3609
2023
Q1
$63K Buy
11,668
+121
+1% +$653 ﹤0.01% 3604
2022
Q4
$78K Sell
11,547
-182
-2% -$1.23K ﹤0.01% 3693
2022
Q3
$90K Buy
11,729
+6,964
+146% +$53.4K ﹤0.01% 3627
2022
Q2
$65K Buy
4,765
+3,936
+475% +$53.7K ﹤0.01% 3950
2022
Q1
$19K Buy
+829
New +$19K ﹤0.01% 4008
2020
Q3
Sell
-18,594
Closed -$398K 3542
2020
Q2
$398K Buy
18,594
+2,411
+15% +$51.6K ﹤0.01% 2942
2020
Q1
$132K Sell
16,183
-95,656
-86% -$780K ﹤0.01% 3178
2019
Q4
$732K Buy
111,839
+76,029
+212% +$498K ﹤0.01% 2758
2019
Q3
$1.71M Buy
35,810
+6,654
+23% +$318K ﹤0.01% 2357
2019
Q2
$967K Buy
29,156
+5,232
+22% +$174K ﹤0.01% 2695
2019
Q1
$939K Buy
23,924
+12,065
+102% +$474K ﹤0.01% 2697
2018
Q4
$262K Buy
11,859
+3,906
+49% +$86.3K ﹤0.01% 3073
2018
Q3
$187K Buy
7,953
+1,724
+28% +$40.5K ﹤0.01% 3164
2018
Q2
$138K Buy
6,229
+1,411
+29% +$31.3K ﹤0.01% 3117
2018
Q1
$125K Buy
+4,818
New +$125K ﹤0.01% 3245
2017
Q4
Sell
-13,447
Closed -$908K 3434
2017
Q3
$908K Buy
+13,447
New +$908K ﹤0.01% 2605
2016
Q2
Sell
-1,129
Closed -$195K 3434
2016
Q1
$195K Sell
1,129
-9,412
-89% -$1.63M ﹤0.01% 3099
2015
Q4
$2.32M Sell
10,541
-3,559
-25% -$782K 0.01% 2009
2015
Q3
$2.84M Buy
14,100
+3,285
+30% +$661K 0.01% 1770
2015
Q2
$1.58M Buy
10,815
+9,356
+641% +$1.37M ﹤0.01% 2208
2015
Q1
$171K Buy
+1,459
New +$171K ﹤0.01% 2924